MCM2 and neoplasm: Prdx2 KO improved liver weight and decreased tumor burden, tumor size, and cell proliferation, as shown at macroscopic observations and by the decreased expression of the proliferation marker minichromosome maintenance complex component 2 (MCM2) (Figure 2, C and D).